Zentalis Pharmaceuticals, Inc.
Support and Resistance Levels
Past performance
News About ZNTL
All events for ZNTL
All deals for ZNTL
Financial Ratios
Financial Statements
ZNTL vs Sector & Peers
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA. Website zentalis.com
Headquarters San Diego, CA, US